Detalhe da pesquisa
1.
Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant.
NPJ Vaccines
; 7(1): 35, 2022 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35260578
2.
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients.
J Hematol Oncol
; 14(1): 174, 2021 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34689821
3.
Evolution of antibody landscape and viral envelope escape in an HIV-1 CRF02_AG infected patient with 4E10-like antibodies.
Retrovirology
; 6: 113, 2009 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-20003438
4.
Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients.
Cancer Cell
; 40(4): 335-337, 2022 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35172125
5.
International network for comparison of HIV neutralization assays: the NeutNet report II.
PLoS One
; 7(5): e36438, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22590544
6.
Characterization of neutralizing profiles in HIV-1 infected patients from whom the HJ16, HGN194 and HK20 mAbs were obtained.
PLoS One
; 6(10): e25488, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22016769
7.
Unravelling the antigenic landscape of the HIV-1 subtype A envelope of an individual with broad cross-neutralizing antibodies using phage display peptide libraries.
J Virol Methods
; 169(1): 95-102, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20637241
8.
Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals.
PLoS One
; 5(1): e8805, 2010 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-20098712
9.
Cross-neutralizing antibodies against primary isolates in African women infected with HIV-1.
AIDS
; 16(3): 501-3, 2002 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-11834970
10.
Neutralization kinetics of sensitive and resistant subtype B primary human immunodeficiency virus type 1 isolates.
J Med Virol
; 78(7): 864-76, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16721864
11.
Inter-subtype cross-neutralizing antibodies recognize epitopes on cell-associated HIV-1 virions.
J Med Virol
; 69(2): 173-81, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12683404
12.
The first generation of candidate HIV-1 vaccines can induce antibodies able to neutralize primary isolates in assays with extended incubation phases.
Vaccine
; 22(1): 104-11, 2003 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-14604577
13.
Epitopes corresponding to the envelope genetic subtype are present on the surface of free virions of HIV-1 group M primary isolates and can be detected in neutralization assays with extended incubation phases.
J Med Virol
; 71(3): 332-42, 2003 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-12966537
14.
Neutralization of primary HIV-1 SF13 can be detected in extended incubation phase assays with sera from monkeys immunized with recombinant HIV-1 SF2 gp120.
Vaccine
; 22(5-6): 747-54, 2004 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-14741168